There will be scheduled network maintenance on this website from 12:00 AM ACST on Friday, April 4th, to 12:00 AM ACST on Sunday, April 6th. We apologise for any inconvenience caused.
February 2025
Heart failure is estimated to affect around 318,000 Australians, with over 60,000 diagnosed every year. The use of recommended medicines is a key factor in reducing hospital admissions and improving survival in people with heart failure with reduced ejection fraction (HFrEF).
November 2024
Diabetes is the fastest growing chronic condition in Australia, increasing at a faster rate than other chronic diseases such as heart disease and cancer. It is important to regularly assess the absolute cardiovascular risk and risk of chronic kidney disease (CKD) for all your patients with T2DM.
Read MoreAugust 2024
By stopping and thinking ‘kidney function’ each time you prescribe medicine for someone you suspect of having reduced kidney function, you can identify patients with CKD and ensure their medicines are safe and effective for them.
Read MoreMay 2024
Improving function is a key goal of persistent pain treatment. Achieving this requires patients to engage in self-management strategies built on an understanding of pain that addresses psychological and social factors and minimises use of pain medicines, particularly opioids.
Read MoreMedicines Advice Initiative Australia (MAIA) is a consortium dedicated to improving the use of medicines and related health services in Australia.
READ MORESign Up For Newsletter
*We will not share your details with any third party.